CareDx Basic EPS 2013-2025 | CDNA
CareDx basic eps from 2013 to 2025. Basic eps can be defined as a company's net earnings or losses attributable to common shareholders per basic share basis.
| CareDx Annual Basic EPS | |
|---|---|
| 2024 | $1.00 |
| 2023 | $-3.54 |
| 2022 | $-1.44 |
| 2021 | $-0.59 |
| 2020 | $-0.40 |
| 2019 | $-0.52 |
| 2018 | $-1.31 |
| 2017 | $-2.38 |
| 2016 | $-2.39 |
| 2015 | $-1.16 |
| 2014 | $0.13 |
| 2013 | $-3.50 |
| 2012 | $-5.01 |
| CareDx Quarterly Basic EPS | |
|---|---|
| 2025-06-30 | $-0.16 |
| 2025-03-31 | $-0.19 |
| 2024-12-31 | $1.61 |
| 2024-09-30 | $-0.14 |
| 2024-06-30 | $-0.09 |
| 2024-03-31 | $-0.38 |
| 2023-12-31 | $-2.21 |
| 2023-09-30 | $-0.43 |
| 2023-06-30 | $-0.46 |
| 2023-03-31 | $-0.44 |
| 2022-12-31 | $-0.34 |
| 2022-09-30 | $-0.32 |
| 2022-06-30 | $-0.41 |
| 2022-03-31 | $-0.37 |
| 2021-12-31 | $-0.31 |
| 2021-09-30 | $-0.23 |
| 2021-06-30 | $-0.04 |
| 2021-03-31 | $-0.01 |
| 2020-12-31 | $-0.05 |
| 2020-09-30 | $-0.06 |
| 2020-06-30 | $-0.15 |
| 2020-03-31 | $-0.14 |
| 2019-12-31 | $-0.11 |
| 2019-09-30 | $-0.04 |
| 2019-06-30 | $-0.19 |
| 2019-03-31 | $-0.18 |
| 2018-12-31 | $-0.07 |
| 2018-09-30 | $-0.54 |
| 2018-06-30 | $-0.40 |
| 2018-03-31 | $-0.30 |
| 2017-12-31 | $-1.30 |
| 2017-09-30 | $-0.63 |
| 2017-06-30 | $-0.19 |
| 2017-03-31 | $-0.26 |
| 2016-12-31 | $-0.61 |
| 2016-09-30 | $-0.20 |
| 2016-06-30 | $-0.77 |
| 2016-03-31 | $-0.81 |
| 2015-12-31 | $-0.41 |
| 2015-09-30 | $-0.29 |
| 2015-06-30 | $-0.27 |
| 2015-03-31 | $-0.19 |
| 2014-12-31 | $0.42 |
| 2014-09-30 | $0.13 |
| 2014-06-30 | $0.87 |
| 2014-03-31 | $-1.29 |
| 2013-12-31 | $-0.56 |
| 2013-09-30 | $-0.82 |
| 2013-06-30 | $-0.79 |
| 2013-03-31 | $-1.33 |
| 2012-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.642B | $0.334B |
| CareDx, Inc. is a commercial stage company. It develops, markets, and delivers a diagnostic surveillance solution for heart transplant recipients. The Company provides AlloMap, a noninvasive blood test used to aid in the identification of heart transplant recipients. It is also pursuing other areas of transplant surveillance, such as the use of cell-free DNA (cfDNA) as a biomarker for rejection. CareDx, Inc. is based in Brisbane, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $142.129B | 26.36 |
| CVS Health (CVS) | United States | $80.640B | 10.03 |
| Elevance Health (ELV) | United States | $63.834B | 8.59 |
| Cencora (COR) | United States | $53.960B | 17.97 |
| DiDi Global (DIDIY) | China | $27.015B | 28.70 |
| Labcorp Holdings (LH) | United States | $21.603B | 17.17 |
| Natera (NTRA) | United States | $19.264B | 0.00 |
| BioMerieux (BMXMF) | France | $17.067B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $14.705B | 0.00 |
| CochLear (CHEOY) | Australia | $13.281B | 0.00 |
| ICON (ICLR) | Ireland | $12.747B | 12.27 |
| Solventum (SOLV) | United States | $12.448B | 12.87 |
| Medpace Holdings (MEDP) | United States | $12.046B | 31.88 |
| Viatris (VTRS) | United States | $11.021B | 3.90 |
| Revvity (RVTY) | United States | $10.036B | 17.68 |
| Sonic Healthcare (SKHHY) | Australia | $8.936B | 0.00 |
| HealthEquity (HQY) | United States | $7.942B | 34.79 |
| Avantor (AVTR) | United States | $7.758B | 11.38 |
| Charles River Laboratories (CRL) | United States | $7.371B | 13.98 |
| Caris Life Sciences,�Inc (CAI) | United States | $7.273B | 0.00 |
| Bausch + Lomb (BLCO) | Canada | $4.885B | 32.86 |
| Amplifon S.p.A (AMFPF) | Italy | $3.937B | 21.83 |
| BrightSpring Health Services (BTSG) | United States | $3.624B | 27.65 |
| Sotera Health (SHC) | United States | $3.185B | 18.10 |
| GeneDx Holdings (WGS) | United States | $3.023B | 69.70 |
| Surgery Partners (SGRY) | United States | $2.977B | 37.45 |
| Alignment Healthcare (ALHC) | United States | $2.745B | 0.00 |
| Concentras Parent (CON) | United States | $2.589B | 16.42 |
| Organon (OGN) | United States | $2.368B | 2.58 |
| Progyny (PGNY) | United States | $1.977B | 41.93 |
| Premier (PINC) | United States | $1.848B | 14.02 |
| PACS (PACS) | United States | $1.690B | 0.00 |
| Ardent Health (ARDT) | United States | $1.641B | 6.34 |
| Pediatrix Medical (MD) | United States | $1.261B | 8.42 |
| GoodRx Holdings (GDRX) | United States | $1.239B | 20.41 |
| Teladoc Health (TDOC) | United States | $1.228B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.040B | 0.00 | |
| Ryman Healthcare (RYHTY) | New Zealand | $0.970B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.656B | 225.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.648B | 8.02 |
| Embecta (EMBC) | United States | $0.605B | 4.08 |
| Performant Healthcare (PHLT) | United States | $0.597B | 0.00 |
| Omada Health (OMDA) | $0.501B | 0.00 | |
| Nutex Health (NUTX) | United States | $0.496B | 7.50 |
| So-Young (SY) | China | $0.490B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.466B | 10.48 |
| Sonida Senior Living (SNDA) | United States | $0.458B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.441B | 0.00 |
| SBC Medicals (SBC) | United States | $0.438B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.414B | 0.00 |
| Enhabit (EHAB) | United States | $0.395B | 26.00 |
| Oncology Institute (TOI) | United States | $0.371B | 0.00 |
| Agilon Health (AGL) | United States | $0.363B | 0.00 |
| LifeMD (LFMD) | United States | $0.313B | 0.00 |
| Beauty Health (SKIN) | United States | $0.200B | 0.00 |
| DocGo (DCGO) | United States | $0.142B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.098B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.095B | 0.00 |
| Biodesix (BDSX) | United States | $0.066B | 0.00 |
| NeueHealth (NEUE) | United States | $0.060B | 0.00 |
| KindlyMD (NAKA) | United States | $0.057B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.052B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.038B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.038B | 0.00 |
| ModivCare (MODV) | United States | $0.033B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.012B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.011B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.010B | 0.00 | |
| SeaStar Medical Holding (ICU) | United States | $0.009B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.008B | 0.00 |
| XWELL (XWEL) | United States | $0.006B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.006B | 0.00 |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| INVO Fertility (IVF) | United States | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |